Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Y-27632 Impairs Angiogenesis on Extra-Embryonic Vasculature in Post-Gastrulation Chick Embryos. | Toxics | 2023 | 36851009 | PubTator, text mining | PubMed |
| Combined Analysis of the Whole Transcriptome of Piglets Infected with SADS-CoV Virulent and Avirulent Strains. | Microorganisms | 2023 | 36838374 | PubTator, text mining | PubMed |
| Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 36834742 | PubTator, text mining | PubMed |
| Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components. | Genes (Basel) | 2023 | 36833199 | PubTator, text mining | PubMed |
| The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients. | Cancers (Basel) | 2023 | 36831555 | PubTator, text mining | PubMed |
| Hyponatremia and Cancer: From Bedside to Benchside. | Cancers (Basel) | 2023 | 36831539 | PubTator, text mining | PubMed |
| Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics. | Cells | 2023 | 36831201 | PubTator, text mining | PubMed |
| Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target. | iScience | 2023 | 36824285 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation. | Essays Biochem | 2023 | 36805653 | PubTator, text mining | PubMed |
| MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. | Cancer Cell Int | 2023 | 36803831 | PubTator, text mining | PubMed |
| Pericyte stem cells induce Ly6G+ cell accumulation and immunotherapy resistance in pancreatic cancer. | EMBO Rep | 2023 | 36802267 | PubTator, text mining | PubMed |
| Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies. | Curr Neuropharmacol | 2023 | 36797611 | PubTator, text mining | PubMed |
| Development of allogeneic hematopoietic stem cell transplantation in 2022: Regenerating "Groot" to heal the world. | Innovation (Camb) | 2023 | 36794169 | PubTator, text mining | PubMed |
| Study on Neuroprotective Mechanism of Houshiheisan in Ischemic Stroke Based on Transcriptomics and Experimental Verification. | Evid Based Complement Alternat Med | 2023 | 36793760 | PubTator, text mining | PubMed |
| Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer. | Front Pharmacol | 2023 | 36778005 | PubTator, text mining | PubMed |
| Highly-expressed lncRNA FOXD2-AS1 in adipose mesenchymal stem cell derived exosomes affects HaCaT cells via regulating miR-185-5p/ROCK2 axis. | Adipocyte | 2023 | 36775902 | PubTator, text mining | PubMed |
| Rho A/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK/RUNX2 axis. | Cell Death Dis | 2023 | 36774349 | PubTator, text mining | PubMed |
| Mechanobiology of the Human Intervertebral Disc: Systematic Review of the Literature and Future Perspectives. | Int J Mol Sci | 2023 | 36769050 | PubTator, text mining | PubMed |
| Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1. | Int J Environ Res Public Health | 2023 | 36767649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=29